Côte d'Ivoire vs Israel: Previously treated cases tested for RR-/MDR-TB
Côte d'Ivoire
100.0%
in 2024
Israel
100.0%
in 2024
Côte d'Ivoire rank
1st
Israel rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Côte d'Ivoire
- Israel
How they compare
Côte d'Ivoire currently reports 100.0% against 100.0% in Israel, a difference of 0.0%.
The two have swapped places 4 times across 16 shared years of data; in 2005 it was Israel ahead.
Côte d'Ivoire ranks 1st and Israel ranks 1st of 180 countries.
Israel has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Côte d'Ivoire | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 8.6% | 83.3% | 74.8% | Israel |
| 2010s | 55.3% | 58.2% | 2.9% | Israel |
| 2020s | 98.4% | 100.0% | 1.6% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Côte d'Ivoire or Israel?
- Côte d'Ivoire, at 100.0% against 100.0% in Israel as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Côte d'Ivoire and Israel?
- 0.0%, with Côte d'Ivoire ahead.
- How many years of comparable data are there for Côte d'Ivoire and Israel?
- 16 years are reported by both, from 2005 to 2024.
- How do Côte d'Ivoire and Israel rank globally for previously treated cases tested for rr-/mdr-tb?
- Côte d'Ivoire ranks 1st and Israel ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.